NCT01887743
Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot Study
See it on ClinicalTrials.gov ↗65 people
61.5%
38.5%
40 womenmiddle line = equal numbers25 men
- Phase
- PHASE1
- Paid for by
- Children's Mercy Hospital Kansas City
- Finished
- 2015-10
- Health conditions
- Obesity, GERD
- Who could join
- Anyone
- Ages
- 6 Years – 17 Years
- Average age
- mean 13.7 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 79.0 percentile for age
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 17 Years.”
- No pregnant women
Women who were pregnant could not join.
“For females, a positive urine beta-human chorionic gonadotropin pregnancy test result”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Non-obese: 10th - 84th percentile for BMI (50 subjects)”
Study titles and rules are shown in their original English.